Literature DB >> 23988369

Systemic mastocytosis in children - therapeutic problems.

Anna Synakiewicz1, Teresa Stachowicz-Stencel, Joanna Renke, Magdalena Lange, Elżbieta Adamkiewicz-Drożyńska, Anna Balcerska.   

Abstract

Systemic mastocytosis is a myeloproliferative disorder characterized by growth and accumulation of abnormal mast cells in one or more organs. The symptoms of the disease are due both to the mast cells infiltrating the organs and to the action of its degranulation products. Over 85% of adult patients exhibit point mutations of KIT at position 816 (D816V). Systemic mastocytosis is rare in both adults and children, so treatment is highly individualized; therapy and further treatment is adjusted to each patient's needs. The aim of this study was to present the case of a 14-year old female with systemic mastocytosis and the problems with her treatment. Multidisciplinary management is recommended in systemic mastocytosis.

Entities:  

Mesh:

Year:  2013        PMID: 23988369

Source DB:  PubMed          Journal:  Med Wieku Rozwoj


  3 in total

Review 1.  Pediatric Mastocytosis: A Review of the Literature.

Authors:  Marianne Frieri; Mahvish Quershi
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2013-12-01       Impact factor: 1.349

2.  Transient hypogammaglobulinaemia of infants in children with mastocytosis - strengthened indications for vaccinations.

Authors:  Joanna Renke; Magdalena Lange; Joanna Dawicka; Elżbieta Adamkiewicz-Drożyńska
Journal:  Cent Eur J Immunol       Date:  2016-10-25       Impact factor: 2.085

Review 3.  Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.

Authors:  Magdalena Lange; Karin Hartmann; Melody C Carter; Frank Siebenhaar; Ivan Alvarez-Twose; Inés Torrado; Knut Brockow; Joanna Renke; Ninela Irga-Jaworska; Katarzyna Plata-Nazar; Hanna Ługowska-Umer; Justyna Czarny; Anna Belloni Fortina; Francesca Caroppo; Roman J Nowicki; Bogusław Nedoszytko; Marek Niedoszytko; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.